PAA 2.38% 20.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1289

  1. 1,841 Posts.
    lightbulb Created with Sketch. 2232
    I would also add, it makes the challenge of funding a bit less of a mountain as it becomes smaller (but significant) chunks and then your cold time things with rebates, grants etc... Yep, the more i type, the more i convince myself.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.